Matches in Nanopublications for { ?s ?p ?o <http://purl.org/np/RAi3L2Rhp8J8-kPelap5qSWLVj4gWAaICd0tCnqRB3-SA#assertion>. }
Showing items 1 to 14 of
14
with 100 items per page.
- DRUGBANK:DB01267 type Drug assertion.
- context type Cohort assertion.
- HP_0000737 type Disease assertion.
- association type Statement assertion.
- association label "Stigler et al. [10] evaluated the effectiveness and tolerability of paliperidone for irritability in ASD. In this 8-week, prospective, open-label study, 21 (84%) of 25 subjects with ASD (mean age, 15.3 years) were considered responders to paliperidone (mean dosage, 7.1 mg/day), based on Clinical Global Impression (CGI)- Improvement and Aberrant Behaviour Checklist-Irritability sub- scale.v" assertion.
- context label "Children and adolescents (mean age 15.3 years)" assertion.
- association subject DRUGBANK:DB01267 assertion.
- association predicate treats assertion.
- association object HP_0000737 assertion.
- association has_population_context context assertion.
- association relation OffLabelIndication assertion.
- association publications 31096228 assertion.
- association provided_by NeuroDKG assertion.
- context has_phenotype MONDO_0005258 assertion.